or Try an Advanced Search...

    Technical Analysis for 0KCC - Oncocyte Corp.

    Grade Last Price % Change Price Change
    C 2.50 0.40% 0.01
    0KCC closed up 0.4 percent on Friday, April 26, 2024, on 2 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: May 9
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent N/A Up Down
    Historical 0KCC trend table...
    Date Alert Name Type % Chg
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Calm After Storm Range Contraction 0.40%
    Narrow Range Bar Range Contraction 0.40%
    Stochastic Reached Oversold Weakness 0.40%
    Wide Bands Range Expansion 0.40%
    Oversold Stochastic Weakness 0.40%
    Older End-of-Day Signals for 0KCC ...

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    TradingView chart

    Profile

    Oncocyte Corp. Description

    OncoCyte Corporation, a molecular diagnostics company, research, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, biopharma, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.

    Classification
    Keywords: Biotechnology Pharmaceutical Medicine Cancer Clinical Medicine Biology Biomarkers Molecular Diagnostics Assay Biochemistry Gene Expression

    Is 0KCC a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.98
    52 Week Low 0.2082
    Average Volume 1,068
    200-Day Moving Average 0.00
    50-Day Moving Average 1.87
    20-Day Moving Average 3.03
    10-Day Moving Average 3.00
    Average True Range 0.44
    RSI (14) 48.45
    ADX 20.78
    +DI 47.43
    -DI 49.03
    Chandelier Exit (Long, 3 ATRs) 3.66
    Chandelier Exit (Short, 3 ATRs) 3.63
    Upper Bollinger Bands 4.19
    Lower Bollinger Band 1.87
    Percent B (%b) 0.27
    BandWidth 76.45
    MACD Line 0.20
    MACD Signal Line 0.36
    MACD Histogram -0.1584
    Fundamentals Value
    Market Cap 1.02 Million
    Num Shares 40.7 Million
    EPS -0.77
    Price-to-Earnings (P/E) Ratio -3.24
    Price-to-Sales 1.81
    Price-to-Book 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.50
    Resistance 3 (R3) 2.50 2.50 2.50
    Resistance 2 (R2) 2.50 2.50 2.50 2.50
    Resistance 1 (R1) 2.50 2.50 2.50 2.50 2.50
    Pivot Point 2.50 2.50 2.50 2.50 2.50
    Support 1 (S1) 2.50 2.50 2.50 2.50 2.50
    Support 2 (S2) 2.50 2.50 2.50 2.50
    Support 3 (S3) 2.50 2.50 2.50
    Support 4 (S4) 2.50